U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678866) titled 'A Preliminary Clinical Study Protocol for Evaluating the Efficacy and Safety of Pulse Electric Field Ablation Systems in Treating Adult Type 2 Diabetes Mellitus With Suboptimal Drug Control' on June 25.
Brief Summary: experiment design: Single-center, single-arm, open-label trial
Inclusion Criteria:
1. Ages 18-70.
2. At least 6 months prior to enrollment, the patient must have been diagnosed with type 2 diabetes mellitus.
3. The glycated hemoglobin level is 7.5%-10.5%.
4. BMI 2 7-40 kg/m2.
5. Patients who, within 12 weeks prior to screening, were treated with 2-3 oral hypoglycemic agents yet still had poorly controlled blood gl...